Clinic Access
U.S. alcohol use drops but heavy drinking persists among older
Oct 9, 2026
Care That Works

FDA approves Jaypirca (pirtobrutinib) as the first noncovalent BTK inhibitor for frontline CLL and SLL treatment in patients without 17p deletion.










U.S. alcohol use fell for the first time since COVID-19, but heavy drinking persists among older adults, with 13% more...





A healthy rice krispie treats recipe that swaps corn syrup and refined oil for sprouted...
Smash chicken caesar tacos transform classic salad flavors into a crispy, protein-rich handheld meal perfect...
LG InnoFest 2026 APAC showcases LG's growth strategy for Asian markets with innovative products tailored...



